Pharmakokinetics for a clinical trial
Description
The project goal is the further development of a method for the quantification of a biopharmaceutical intended to treat an auto-immune disease. For that purpose, sera of clinical trial subjects are being analyzed employing a previously established pharmacokinetics method to corroborate its applicability.
Key Data
Projectlead
Project status
completed, 10/2020 - 06/2022
Funding partner
Third party